Decision support tools in the absence of equipoise: the case for vaccination
Daphne Bussink-Voorend, Marlies EJL Hulscher, Glyn Elwyn

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
- —http://dx.doi.org/10.13039/501100001826ZonMw
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsVaccine Coverage and Hesitancy · Influenza Virus Research Studies · Genomics and Rare Diseases
Public health is in a bind. The goal of the discipline is to protect and improve the public’s overall health so that populations remain as healthy as possible. Public health considers decisions from a Malthusian perspective: what is good for the overall population and often sidesteps the issue of personal choice, and the extent to which that choice is informed or not. What should public health do about individuals who, informed or otherwise, act in ways that threaten their health or that of others, for instance, by smoking, declining screening and refusing vaccinations?
Individual behaviour should be understood within a broader context, where many factors and societal developments drive behaviours such as smoking and vaccine refusal. For example, decision-making about vaccination is shaped by a perceived need to vaccinate, concerns about safety, social networks and norms, past experiences with healthcare services and institutional trust. Vaccine refusal is highly context dependent.1 Therefore, vaccination cannot be viewed solely as an individual health choice. At the same time, this should not stop us proposing interventions targeted at individuals as part of broader public health strategies. Vaccination is ideally suited for this purpose, as choices made by individuals impact others through the protective effect of group immunity.
In healthcare, tools are being increasingly developed to support individual decision-making, particularly when comparing reasonable treatment options to assess benefit-harm trade-offs. These tools come in various formats, ranging from brief comparison tables to more comprehensive web applications. They are designed to support shared decision-making between healthcare professionals and their patients, which leads to better patient knowledge, better risk perceptions, and greater clarity about personal preferences.2 Moreover, decision support tools are typically developed in co-creation with end-users to increase acceptability, usability and relevance.
Public health information efforts have largely avoided this comparative approach, instead providing recommendations rather than comparing whether to accept or reject an intervention and involving community voices.3 Is it possible to advocate for the use of client-facing decision support tools in public health?
Shared decision-making is ideal when multiple options are reasonable, a situation termed equipoise. The guidelines established by the International Patient Decision Aid Standard collaboration advocate a balanced representation of options. Yet, it is also acceptable to use a shared decision-making approach in situations where options are not entirely balanced.4 For example, in the case of vaccination, broader societal interests are relevant alongside individual preferences.5 Evidence supports uptake, because the risk of harm is very low compared with the benefits of avoiding illness. Therefore, when there is clear evidence of population-level benefits, developers of decision support tools should strive for a different kind of balance that reflects the evidence. They should be clear about the overwhelming benefits to both individuals and populations, while also being equally clear about the very low risk of harm. Alternative criteria are needed to guide the design of decision support for situations where broader interests need to be considered, as well as the preponderance of evidence.
Emphasising personal choice can be at odds with public health’s emphasis on the overall population. Yet, vaccination coverage in a given population is the result of multiple individual choices. Because the consequences of these individual vaccination decisions also impact a wider society, it is in the public interest to support these choices with trustworthy information. This is especially true when people make choices in the face of pervasive misinformation and disinformation and the politicisation of public health topics.6 7 The decline in vaccine uptake rates and the resurgence of vaccine-preventable diseases highlight the high relevance of this topic.8
In times of fear and confusion, it is not only important to clearly communicate the benefits and harms of vaccination, but also to listen and respect other people’s views. Approaching vaccination as a strict medical consideration does not do justice to the relevance of social processes, institutional trust and political trends.1 Considering how these factors shape individual concerns about vaccination improves our understanding of how to relate to vaccine-hesitant individuals and which factors drive acceptance. An open dialogue about concerns, emotions and values, which is central to shared decision-making, is a good starting point. Logically, we need to design tools that support this process. Decision support tools about vaccination should also reflect deep community engagement, political awareness and cultural sensitivity to build trust and ensure their relevance. This is best accomplished through collaboration in multidisciplinary teams of community members, clinicians, biomedical and social scientists and public health professionals.
Our understanding of how to design decision support tools has evolved, resulting in a body of knowledge about their practical use. We should also harness this potential to ethically promote public health interventions where it is essential to balance societal interests alongside respect for individual choice.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1DubéÈ Ward JK Verger P et al Vaccine Hesitancy, Acceptance, and Anti-Vaccination: Trends and Future Prospects for Public Health Annu Rev Public Health 2021421759110.1146/annurev-publhealth-090419-10224033798403 · doi ↗ · pubmed ↗
- 2Stacey D Lewis KB Smith M et al Decision aids for people facing health treatment or screening decisions Cochrane Database Syst Rev 20241 CD 00143110.1002/14651858.CD 001431.pub 638284415 PMC 10823577 · doi ↗ · pubmed ↗
- 3Oxman AD Fretheim A Lewin S et al Health communication in and out of public health emergencies: to persuade or to inform? Health Res Policy Sys 2022202810.1186/s 12961-022-00828-z PMC 889776135248064 · doi ↗ · pubmed ↗
- 4Opel DJ Gerstein MT Carle AC et al Saving Shared Decision-Making J Gen Intern Med 2025401844710.1007/s 11606-025-09410-z 39953310 PMC 12119428 · doi ↗ · pubmed ↗
- 5Elwyn G Price A Franco JVA et al The limits of shared decision making BMJ Evid Based Med 2023282182110.1136/bmjebm-2022-112089 PMC 1042347636522136 · doi ↗ · pubmed ↗
- 6Paoletti G Dall’Amico L Kalimeri K et al Political context of the European vaccine debate on Twitter Sci Rep 202414439710.1038/s 41598-024-54863-738388713 PMC 10883931 · doi ↗ · pubmed ↗
- 7van der Linden S Misinformation: susceptibility, spread, and interventions to immunize the public Nat Med 202228460710.1038/s 41591-022-01713-635273402 · doi ↗ · pubmed ↗
- 8Kuppalli K Perl TM Measles in Texas: waning vaccination and a stark warning for public health Lancet Infect Dis 202525485710.1016/S 1473-3099(25)00162-840086464 · doi ↗ · pubmed ↗
